课题基金 / 基金详情

Establishment and clinical application of the stable expression system of mutant gene for alpha-subunit of pyruvate dehydrogenase

Establishment and clinical application of the stable expression system of mutant gene for alpha-subunit of pyruvate dehydrogenase
丙酮酸脱氢酶α亚基突变基因稳定表达体系的建立及临床应用
批准号:
08670893
负责人:
ITO Michinori
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

ITO Michinori的其他基金

相似基金

相关文献

中文摘要
翻译
丙酮酸脱氢酶α亚单位(E1pha)缺乏是先天性乳酸血症最常见的原因之一。丙酮酸脱氢酶复合体(PDHC)由6个组分组成,因此,对于除E1a外其他成分正常的宿主细胞,建立突变的E1a蛋白表达系统,以确认E1a基因突变的致病作用,并检测E1a缺乏症患者E1a的功能异常,是必要的。然后,我们为人细胞制备了含有CAG启动子和正常E1a基因的稳定表达载体,并将该载体导入E1a缺陷的淋巴母细胞。经转染和筛选后,E1pha缺失的淋巴母细胞显示出正常的PDHC活性和正常的E1pha蛋白含量。有了这个表达系统,我们就可以确认E1pha基因突变的致病性,并检测突变的E1pha蛋白的功能异常。因此,我们制备了含有E1a缺乏症患者突变E1pha基因的表达载体。此外,我们还通过X染色体失活偏差分析、SSCP和直接测序,在1例女性先天性乳酸血症患者中发现了新的105bp插入突变,具有正常的PDHC活性。
英文摘要
Pyruvate dehydrogenase alpha-subunit (E1alpha) deficiency is one of the most common causes of congenital lactic acidemia. Pyruvate dehydrogenase complex (PDHC) consists of six components, so that host cells which have normal other components except E1alpha, to establish the expression system with mutant E1alpha protein for confirmation of pathogenesity of mutation in E1alpha gene and exmination of functional abnormality of E1alpha in patients with E1alpha deficiency, are necessary. Then, we prepared the stable expression plasmid vector with CAG promoter and normal E1alpha cDNA for human cells and transfected this plasmid vector into lymphoblastoid cells with E1alpha deficiency. After transfection and selection, the lymphoblastoid cells with E1alpha deficiency showed the normal PDHC activity and normal amount of E1alpha protein. With this expression system, we became to confirm the pathogenesity of mutations in E1alpha gene and examine the functional abnormality of mutant E1alpha proteins. So, we prepared the expression vector containing mutant E1alpha cDNA found in patients with E1alpha deficiency. Furthermore, we found the new mutation, 105bp insertion, in a female patient with congenital lactic acidemia, having normal PDHC activity with the assay of deviation of X-chromosome inactivation, SSCP and the direct sequencing.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Saijo T,Naito E,Ito M,Matsuda J,Yokota I,Kuroda Y: "Stable Restoration of Pyruvate dehydrogenase Complex in E1-Defective Human Lymphoblastoid Cells." Bioch Biophys Res Commun. 228. 446-45 (1996)
Saijo T、Naito E、Ito M、Matsuda J、Yokota I、Kuroda Y:“E1 缺陷的人淋巴母细胞中丙酮酸脱氢酶复合物的稳定恢复。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Saijo T et al: "Stable Restoration of Pyruvate dehydrogenase Complex in E1-Defective Human Lymphoblastoid Cells" Bioch Biophy Res Commun. 228. 446-451 (1996)
Saijo T 等人:“E1 缺陷的人淋巴母细胞中丙酮酸脱氢酶复合物的稳定恢复”Bioch Biophy Res Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Molecular Genetical Analysis of New Cause for Congenital Lactic Acidemia
  • 批准号:
    12670754
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2000
  • 负责人:
    ITO Michinori
  • 依托单位:
Molecular Biological Analysis of Congenital Lactic Acidemia
  • 批准号:
    10670734
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.11万
  • 财政年份:
    1998
  • 负责人:
    ITO Michinori
  • 依托单位:
The study of cauces of mitochondrial cytopathy
  • 批准号:
    05670679
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1993
  • 负责人:
    ITO Michinori
  • 依托单位:
海外基金